Advertisement

Venus Concept Inc. VERO

Set alert

Price alert · VERO

All alert types
0.31 USD 0.00 0.00%

At close · Apr 6

1.08 +0.77 +247.27%

After hours · Apr 6, 4:00 PM ET

Bid
1.11 × —
Ask
1.13 × —
0.2683 Day range 0.311
0.277 52-week range 2.22
YTD
-78.99%
1 year
-86.82%
Open
0.2683
Prev close
0.311
Mkt cap
2.33M
Vol
43
Avg vol
1.25M
EPS
-7.97
P/E
0.00
Div yield
0.00%
More statistics
Low
0.2683
High
0.311
Forward P/E
-0.14
Beta
0.64
Short ratio
0.69
Inst. own
27.03%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
0.37878
200-d avg
0.58925
1y target
0.00

2Y chart

Chart tools
Interval
VERO two-year price chart0.254.568.8713.217.5Apr 24Aug 24Jan 25Jun 25Nov 25Apr 26

Key statistics

Market cap
2.33M
Enterprise value
47.50M
Trailing P/E
0.00
Forward P/E
-0.14
PEG ratio
0.00
Price / sales
0.03
Price / book
0.00
EPS (TTM)
-7.97
Beta
0.64
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-71.52%
Revenue (TTM)
69.81M
Revenue growth
-17.40%
Free cash flow
-1.06M
Total cash
5.73M
Total debt
50.03M
Return on equity
0.00%
Shares outstanding
7.26M
Short % of float
28.86%
50-day average
0.37878
200-day average
0.58925

Analyst view

Consensus: none

Price target (mean) 0.00
Ratings (0m) 3 0 buy · 3 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold3
  • Sell0
  • Strong sell0

Next earnings

Aug 13, 2024

Expected Aug 13, 2024. Consensus EPS estimate -0.92.

Earnings history

Financials — quick view

All financials
VERO Revenue — quarterly 13.78M
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025
VERO Net income — quarterly -22.57M
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025
VERO EPS — quarterly -12.14
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025

Earnings

VERO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 13, 2024Sep 1, 20240.00-1.28——
Aug 13, 2024Jun 1, 20240.00-1.39——
Aug 13, 2024Jun 1, 20240.00———
May 15, 2024Mar 1, 20240.00———
May 15, 2024Mar 1, 20240.00-1.68——
Apr 1, 2024Dec 1, 20230.00-2.01——

Upgrades / downgrades

VERO analyst upgrades and downgrades
DateFirmActionFromTo
Oct 6, 2023BTIGdownBuyNeutral

About Venus Concept Inc.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Sector
Healthcare
Industry
Medical Devices
Country
Canada
Website
venus.ai

News

Your note

Sign in to keep a note on VERO — it syncs with the Stock Master app.

Insider holders

VERO insider holders
InsiderRelationLatest transactionDateShares held
DELLA PENNA DOMENICOfficerStock Award(Grant)Mar 23, 2023151,385
GEORGIADIS ANNAOfficerStock Award(Grant)Mar 23, 202325,659
MANDARELLO MICHAELGeneral CounselStock Award(Grant)Aug 10, 20231,491
MASTERS MICHAEL WILLINGHAMBeneficial Owner of more than 10% of a Class of SecuritySaleOct 2, 20240
MCGRAIL WILLIAM HOfficerStock Award(Grant)Mar 23, 20237,783
NATALE ANTHONYDirectorSaleDec 2, 20240

Institution ownership

VERO institution ownership
Holder% heldSharesValueReported
Essex Woodlands Management Inc.15.01%1,089,190349.08KSep 29, 2024
Masters Capital Management, LLC8.57%621,740199.27KSep 29, 2024
Vanguard Group Inc0.45%32,43810.40KSep 29, 2024
Geode Capital Management, LLC0.40%29,0559.31KSep 29, 2024
HRT Financial LP0.25%18,1385.81KSep 29, 2024
Firethorn Wealth Partners, LLC0.14%10,0503.22KSep 29, 2024

Fund ownership

VERO fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.45%32,43810.40KSep 29, 2024
Fidelity Extended Market Index Fund0.32%22,9447.35KOct 30, 2024
Fidelity Series Total Market Index Fund0.08%6,1141.96KOct 30, 2024
Fidelity Total Market Index Fund0.01%1,079345Oct 30, 2024
Nuveen Nasdaq 100 Dynamic Overwrite Fund0.00%10Oct 30, 2024
Advertisement